Moneycontrol PRO

Rossari Biotech: Market share gain in textile chemicals is comforting

In the longer term, what we like about Rossari Biotech is that it's led by technocrats with strong domain knowledge, which in turn has helped in superior execution of capex projects in the past and diversification into new end-markets

January 27, 2021 / 09:52 AM IST
Rossari Biotech: Market share gain in textile chemicals is comforting

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

Highlights - Traction in cleanliness and hygiene categories - Signs of market share gains in textile chemicals - Animal health witnesses dip in demand - Dahej plant to be fully commissioned by March’21 - Deserves high multiples given growth traction and project execution Rossari Biotech (Market cap: Rs 4,572 crore, CMP: Rs 880) posted yet another strong topline performance, backed by opportunities in chemicals used for cleanliness. Further, this largest manufacturer of textile chemicals in India, observed market share gains in the legacy business. However, a drop in the animal health...

  • PRO Panorama

    Moneycontrol Pro Panorama | Is Omicron losing its sting? 

    Jan 20, 2022 / 04:08 PM IST

    In today’s edition of Moneycontrol Pro Panorama: ICICI Lombard makes the cut, the way forward for L&T Infotech, Budget Chart of the Day, Crypto Learn and more

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender | Bubble Trouble 

    Jan 22, 2022 / 10:01 AM IST

    The US is in the grip of “three and a half bubbles”, according to GMO’s chief investment strategist Grantham

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers